⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

July 26, 2026Molecular Pharmaceutics

Auger Electron Therapy Enhanced by Heat-Triggered Release of I-125-Labeled DNA-Targeted Compounds within the Tumor Microenvironment

Masayuki Munekane Kazuki Matsunaga Miki Ozaki Hiroaki Echigo Kenji Mishiro Takeshi Fuchigami Kazuma Ogawa

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to enhance Auger electron therapy by using heat-triggered release of I-125-labeled compounds in the tumor microenvironment.
Utilized I-125-loaded thermally sensitive liposomes (TSLs)
Applied hyperthermia to trigger the release of compounds
Targeted the nuclei of cancer cells within the tumor microenvironment.
Demonstrated improved targeting of cancer cells compared to standard treatments.
Enhanced therapeutic effect was observed with the combination of TSLs and hyperthermia.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Shows enhanced tumor targeting in cancer cells, indicating a new therapeutic approach.

Abstract

I]I-DOX-loaded TSLs and hyperthermia represents a promising strategy for Auger electron therapy targeting the nuclei of cancer cells.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Munekane et al. (2026) studied this question.

synapsesocial.com/papers/6a69a2e2c8da07d9defa6f1b https://doi.org/10.1021/acs.molpharmaceut.6c00443

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Auger-Emitting Radionuclides in Radiopharmaceutical Research: Decay-Associated Processes, Vector-Dependent Localization, and Translational PerspectivesReview · 2026 · 1 citations
2Dual-laser “808 and 1,064 nm” strategy that circumvents the Achilles’ heel of photothermal therapyOriginal Research · 2025 · 72 citations
3Dual-locked targeted alpha-emitter enhanced tumor immunotherapy via Diels–Alder reaction-based self-immolative molecular cage strategy2025 · 1 citations
4Dual-loaded homotypic exosomes with endogenous IR808 and pH-responsive DOX drive sequenced chemo-PDT and convert “cold” OSCC tumors “hot”Original Research · 2026 · 3 citations
5Multifunctional Hybrid Hydrogel Enhanced Antitumor Therapy through Multiple Destroying DNA Functions by a Triple‐Combination Synergistic TherapyOriginal Research · 2021 · 34 citations
6Nanoigniter-Integrated Microneedle Patches for Boosted Photothermal-Mediated Multimodal Therapy: In Situ Tumor Microenvironment Igniting StrategyOriginal Research · 2025 · 13 citations
7DDEL-02. Laser Interstitial Thermal Therapy for Targeted CNS Delivery of Chemotherapy: Pre-Clinical Results and Planned Clinical Trial2025
8PeptoBrush Enables Sustained Release of Auger Radiotherapeutic [ <sup>125</sup> I]Iododeoxyuridine for Glioblastoma TreatmentOriginal Research · 2026
9Oxidation Mechanisms and Control Strategies in Peptide and Protein FormulationsMolecular Pharmaceutics · 2026
10ABCB1, ABCG2, and CES1 are Key Determinants of the Pharmacokinetics of KRASG12C Inhibitor DivarasibMolecular Pharmaceutics · 2026

More from Molecular Pharmaceutics

More from Kanazawa University